AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2026 Quarter 4; ICD-10-PCS New/Revised Codes Section 3 – Administration
High-Dose Immune Globulin
In the Administration Section, table 302 , Transfusion of Circulatory, qualifier value 5 for High-Dose Immune Globulin, was added to body region values 3 Peripheral Vein, and 4 Central Vein, substance value S Globulin, and approach value 3 Percutaneous, to capture the intravenous administration infusion of high-dose immune globulin. Body System/ Region Approach Substance Qualifier 3 Peripheral Vein 4 Central Vein 3 Percutaneous S Globulin 5 Immune Globulin, High-Dose High-dose intravenous immunoglobulin (HD-IVIg) therapy, that administers substances such as GAMUNEX-C, is used to treat primary humoral immunodeficiency, idiopathic thrombocytopenic purpura, and chronic inflammatory demyelinating polyneuropathy. HD-IVIg is an immunomodulatory agent...
Subscribe or sign in to view the full article.
Article Overview
The article discusses a change in the ICD-10-PCS Administration Section and places high-dose intravenous immune globulin in the context of several immune-related conditions. It is relevant to coding professionals and clinicians seeking an overview of the update and its clinical subject matter.
Why This Topic Matters
The article connects an ICD-10-PCS administration-table update with the clinical context of high-dose intravenous immune globulin, helping readers identify whether the topic is relevant to their coding or clinical work.
What You Will Learn
- The subject and general scope of the ICD-10-PCS Administration Section update
- The clinical context discussed for high-dose intravenous immune globulin
- The types of conditions mentioned in connection with the therapy
- intended_audiences
- topics
- medical_specialties
- code_sets
- codes
Who Should Read This
- Medical coders
- Health information management professionals
- Clinicians involved in immune-related care
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com